Renal Biomarkers Market Research Report, Share, and Forecast to 2025

Posted by rekha on October 3rd, 2019

 Precision Business Insights (PBI) in its report titled “Global Renal Biomarkers Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014 to 2018 and Forecast 2019 to 2025” assesses the market performance over six years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The Global Renal Biomarkers market was valued around US$ 1,000.0 Mn in 2018 and projected to reach US$ 1,600.0 Mn by 2025 owing to increase in renal disorders due to high blood pressure coupled with diabetes and cardiovascular diseases. The advanced technologies i.e., biomarkers cystanin C, Kidney Injury Molecule M (KIM-1), Interleukin – 18 have able to diagnose the Kidney Disease. Surge in the R&D expenditure in order to offer the innovative solutions for unmet needs is anticipated to create the demand for ‘renal biomarkers’ across the globe. However, stringent regulations coupled with high price are expected to be major bottlenecks for the global renal biomarkers market over forecast years.

Global Renal Biomarkers market segmented on the basis of biomarker type, by diagnostic technique, by end-user and country

For request sample: https://www.precisionbusinessinsights.com/request-sample?product_id=23471

Functional Biomarkers are Projected to Expand at Robust CGARs over the Forecast Timeframe.

 Based on biomarker type, global renal biomarkers market segmented into functional biomarkers, up-regulated biomarkers, and others. The functional biomarkers segment projected to dominate the market share over the forecast period. The functional biomarkers are mainly used for glomerular changes or impaired tubular reabsorption biomarkers.

Chemiluminescent Enzyme Immunoassay Segment Expected to Witness Lucrative Opportunities over the Forecast Period

Based on the diagnostic technique, global renal biomarker market segmented into particle enhanced turbidimetric immunoassay, chemiluminescent enzyme immunoassay, Enzyme linked immunosorbent assay, Colorimetric assay, Liquid chromatography. Enzyme Linked Immunosorbent Assay (ELISA), accounted for major share in 2018, and projected to dominate the market over the forecast timeframe.  Chemiluminescent enzyme immunoassay segment is anticipated to expand at a CAGR of 7.8% over the forecast timeline, and projected to account the significant revenue share in future.

Germany Renal Biomarkers Market Registered Robust Growth Rate in Europe Renal Biomarkers Market

 Precision Business Insights (PBI) Global Renal Biomarkers market report analyses the market in different regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America is projected to dominate the revenue share of global renal biomarkers market.  U.S. renal biomarkers market has accounted for 89.5% of revenue share in 2018, and projected to continue the lion share over the forecast period.  Surge in the number of baby boomers in the U.S., coupled with burgeoning the prevalence of obesity, hypertension, cardiovascular disorders are expected to fuel the demand for renal biomarkers market. 

Europe renal biomarkers market has been expanding at significant CAGR from 2019 to 2025. Increasing prevalence of renal disorders coupled with surge in R&D investments are expected to offer lucrative opportunities for the market players.

Asia Pacific renal biomarkers market projected to unlock the potential of the market in near future due to soaring the geriatric population coupled with increased prevalence of renal disorders.

Strategic Collaborations, and Launch of New Products are Major Strategies to Gain Market Share.

 Global renal biomarkers market players are focused on new product introductions coupled with strategic mergers and acquisitions in order to strengthen the market presence by expanding the distribution channel.

Key player’s profiles in the report are Merck Millipore (U.S), Thermo Fisher Scientific, Inc. (U.S.), Hoffmann-La Roche Ag (Switzerland), Abbott Molecular, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Astute Medical, Inc. (U.S.), Randox Laboratories Ltd (Ireland), and among others.

Detailed Segmentation

By Biomarker Type

o     Functional Biomarkers

o   Serum Cystatin C

o   Serum Creatinine

o   Urine Albumin

o     Up-Regulated Biomarkers

o   Kidney Injury Molecule-1 (KIM-1)

o   Nutrophil Gelatinase Associated Lipocalin

o   Interleukin 18

o      Others

By Diagnostic Technique Type

o     Particle enhanced turbidimetric immunoassay

o     Chemiluminescent enzyme immunoassay

o     Enzyme linked immunosorbent assay

o     Colorimetric assay

o     Liquid chromatography

By End-User

o     Hospitals

o     Outpatient Clinics

o     Research Centers

o     Diagnostic Labs

o      

Geography

o   North America

o   U.S.

o   Canada

o   Europe

o   Germany

o   UK

o   France

o   Spain

o   Italy

o   Russia

o   Poland

o   Rest of Europe

o   Asia Pacific

o   India

o   China

o   Japan

o   AU and NZ

o   Rest of Asia-Pacific

o   Latin America

o   Brazil

o   Mexico

o   Argentina

o   Rest of Latin America

o   Middle East and Africa

o   GCC Countries

o   South Africa

o   Rest of Middle East and Africa

For more information: https://www.precisionbusinessinsights.com/market-reports/renal-biomarkers-market/